KSC · 207940.KS
Samsung Biologics Co.,Ltd.
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
Loading market information…
KOE · 468530.KQ · KRW
Stock price
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Proteina Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Proteina Co., Ltd. is dedicated to pioneering technology for characterizing protein-protein interactions (PPIs). Their innovative approach enables the direct visualization of specific proteins to confirm the real-time activation of cancer signaling pathways. This capability helps predict drug efficacy and, crucially, empowers medical professionals to select optimal inhibitors by identifying bypass pathways that contribute to drug resistance. The company further offers a distinct single-molecule protein interaction detection platform, designed for in-depth analysis of protein and PPI information. Founded in 2015, Proteina Co., Ltd. is headquartered in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
₩191,600+₩2,300 (+1.22%)
Celltrion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.85% below the high.
₩211,500-₩8,500 (-3.86%)
Alteogen Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.68% below the high.
₩309,500+₩2,500 (+0.81%)
Samsung Epis Holdings’s quoted price sits in the lower half of its reported 52-week range, 59.96% below the high.
₩9,970+₩70 (+0.71%)
Genomictree Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.06% below the high.
₩9,100+₩520 (+6.06%)
GC Genome Corporation’s quoted price sits in the upper half of its reported 52-week range, 13.17% below the high.
₩2,875-₩155 (-5.12%)
Oncocross Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.16% below the high.
₩2,395₩0 (0.0%)
IMBdx’s quoted price sits in the lower half of its reported 52-week range, 81.51% below the high.
